JASMINA DUKOVIC: Open Payments
NPI 1457021677 · DOWNEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,842 in 68 payments from 21 companies in 2025. Trend: 2023 $1,255 · 2024 $2,067 · 2025 $1,842
Food & beverage: $1,639Education: $203
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 9 | $265 |
| Sumitomo Pharma America, Inc. | 10 | $243 |
| Janssen Biotech, Inc. | 6 | $176 |
| ACCORD HEALTHCARE, INC. | 3 | $151 |
| UROGEN PHARMA, INC. | 9 | $140 |
| Astellas Pharma US Inc | 2 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $112 |
| ABBVIE INC. | 3 | $75 |
| Teleflex LLC | 2 | $71 |
| IMMUNITYBIO, INC. | 3 | $62 |
Products named: PROVENGE, ERLEADA, ORGOVYX, Camcevi, Nubeqa, GEMTESA, LUPRON DEPOT, UROLIFT.
Industry payments across CA — which companies pay providers there.
